Survival in scleroderma.
作者信息
Bennett R, Bluestone R, Holt P J, Bywaters E G
出版信息
Ann Rheum Dis. 1971 Nov;30(6):581-8. doi: 10.1136/ard.30.6.581.
Abstract
摘要
相似文献
1
Survival in scleroderma.硬皮病的生存率
Ann Rheum Dis. 1971 Nov;30(6):581-8. doi: 10.1136/ard.30.6.581.
2
Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients.
Ann Intern Med. 1971 Sep;75(3):369-76. doi: 10.7326/0003-4819-75-3-369.
3
[Survival and prognostic significance of a kidney lesion in systemic scleroderma].
Ter Arkh. 1982;54(7):99-102.
4
Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival.系统性硬化症患者死亡率的预测：对309名法裔加拿大患者队列的分析，重点关注诊断时的特征作为生存预测因素。
Medicine (Baltimore). 2002 Mar;81(2):154-67. doi: 10.1097/00005792-200203000-00005.
5
Characteristics of patients with juvenile onset systemic sclerosis in an adult single-center cohort.成人单中心队列中青少年发病系统性硬皮病患者的特征。
J Rheumatol. 2010 Nov;37(11):2422-6. doi: 10.3899/jrheum.100001. Epub 2010 Sep 15.
6
The prognosis of systemic sclerosis.
Br J Dermatol. 1976 Jul;95(1):57-60. doi: 10.1111/j.1365-2133.1976.tb15535.x.
7
[Progressive systemic scleroderma--prognosis determining involvement of internal organ systems].
Hautarzt. 1998 Jul;49(7):545-51. doi: 10.1007/s001050050786.
8
Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.无硬皮病的系统性硬化症：48例患者的人口统计学、临床和血清学特征及生存率
Arthritis Rheum. 2000 Feb;43(2):444-51. doi: 10.1002/1529-0131(200002)43:2<444::AID-ANR27>3.0.CO;2-G.
9
Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China.系统性硬化症的预后特征：中国 EUSTAR 临床队列分析。
Arthritis Res Ther. 2018 Oct 22;20(1):235. doi: 10.1186/s13075-018-1735-4.
10
[Systemic scleroderma].
Nihon Rinsho. 1993 Jan;51 Suppl:527-34.
引用本文的文献
1
Mortality and morbidity in scleroderma renal crisis: A systematic literature review.硬皮病肾危象中的死亡率和发病率：一项系统文献综述。
J Scleroderma Relat Disord. 2021 Feb;6(1):21-36. doi: 10.1177/2397198320920422. Epub 2020 Jun 1.
2
Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality.局限型硬皮病、弥漫型硬皮病和系统性硬化症的生存和死亡率预测因素。
Arthritis Res Ther. 2021 Dec 7;23(1):295. doi: 10.1186/s13075-021-02672-y.
3
Update on Morbidity and Mortality in Systemic Sclerosis-Related Interstitial Lung Disease.系统性硬化症相关间质性肺疾病的发病率和死亡率最新情况
J Scleroderma Relat Disord. 2021 Feb;6(1):11-20. doi: 10.1177/2397198320915042. Epub 2020 May 22.
4
Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China.系统性硬化症的预后特征：中国 EUSTAR 临床队列分析。
Arthritis Res Ther. 2018 Oct 22;20(1):235. doi: 10.1186/s13075-018-1735-4.
5
Derivation and validation of a prediction rule for two-year mortality in early diffuse cutaneous systemic sclerosis.早期弥漫性皮肤系统性硬化症两年死亡率预测规则的推导和验证。
Arthritis Rheumatol. 2014 Jun;66(6):1616-24. doi: 10.1002/art.38381.
6
Preliminary study of cardiovascular manifestations and cardiac severity scale in 58 patients with systemic sclerosis in iran using the medsger scale.使用梅兹格量表对伊朗58例系统性硬化症患者心血管表现及心脏严重程度量表的初步研究。
J Tehran Heart Cent. 2010 Winter;5(1):14-8. Epub 2010 Feb 28.
7
Survival in progressive systemic sclerosis with pulmonary involvement: a single-center experience in Istanbul, Turkey.土耳其伊斯坦布尔单中心经验：肺受累的进行性系统性硬化症的生存情况。
Rheumatol Int. 2012 Jun;32(6):1655-61. doi: 10.1007/s00296-011-1842-x. Epub 2011 Mar 5.
8
Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma.皮肤厚度进展率：硬皮病弥漫型患者死亡率和早期内脏器官受累的预测指标。
Ann Rheum Dis. 2011 Jan;70(1):104-9. doi: 10.1136/ard.2009.127621. Epub 2010 Aug 2.
9
Clinical and genetic factors predictive of mortality in early systemic sclerosis.早期系统性硬化症患者死亡率的临床和遗传预测因素
Arthritis Rheum. 2009 Oct 15;61(10):1403-11. doi: 10.1002/art.24734.
10
Complete heart block in a patient with systemic sclerosis.
Clin Rheumatol. 2006 Jul;25(4):551-2. doi: 10.1007/s10067-005-0068-2. Epub 2005 Nov 1.
本文引用的文献
1
Acrosclerosis.顶体硬化
Br Med J. 1951 Oct 13;2(4736):873-6. doi: 10.1136/bmj.2.4736.873.
2
Prognostic significance of Raynaud's phenomenon and other clinical characteristics of systemic scleroderma. A study of 271 cases.雷诺现象及系统性硬化症其他临床特征的预后意义。一项对271例病例的研究。
Circulation. 1960 Jun;21:1088-95. doi: 10.1161/01.cir.21.6.1088.
3
Systemic scleroderma, A clinical study of 727 cases.系统性硬化症：727例临床研究
Arch Dermatol. 1961 Sep;84:359-71. doi: 10.1001/archderm.1961.01580150005001.
4
Statistics; servant of all sciences.统计学；所有科学的工具。
Science. 1955 Sep 2;122(3166):401-6. doi: 10.1126/science.122.3166.401.
5
Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus.以系统性红斑狼疮为例的慢性病预后判定
J Chronic Dis. 1955 Jan;1(1):12-32. doi: 10.1016/0021-9681(55)90018-7.
6
Scleroderma (diffuse systemic sclerosis).硬皮病（弥漫性系统性硬化症）。
Proc R Soc Med. 1953 Jul;46(7):507-11. doi: 10.1177/003591575304600706.
7
Epidemiology of fatal systemic sclerosis (diffuse scleroderma). A 15-year survey in Baltimore.致死性系统性硬化症（弥漫性硬皮病）的流行病学。在巴尔的摩进行的一项为期15年的调查。
Ann Intern Med. 1967 May;66(5):870-83. doi: 10.7326/0003-4819-66-5-870.
8
Lung function and the response to exercise in systemic sclerosis.系统性硬化症中的肺功能及运动反应
Thorax. 1969 Jul;24(4):427-34. doi: 10.1136/thx.24.4.427.
9
Systemic sclerosis and small bowel involvement.系统性硬化症与小肠受累
Gut. 1969 Mar;10(3):185-93. doi: 10.1136/gut.10.3.185.
Zotero 插件